Femtech World is excited to reveal the shortlist for the inaugural Fertility Innovation award.
The award is one of 11 up for grabs at Femtech World’s second annual awards event, which celebrates the best examples of leadership, innovation and impact in key areas that affect women’s health and wellbeing.
The Fertility Innovation Award, sponsored by FinDBest IVF aims to shine a light on the life-changing work of those developing next-generation innovations that could not only increase success rates but revolutionise the world of reproductive health as we know it.
FinDBest IVF is where innovation meets efficiency in the IVF medical device market.
The company connects IVF medical device manufacturers with over 750 pre-vetted distributors in over 150 countries.
Supported by seasoned MedTech experts, FinDBest IVF ensures quality partnerships, global reach, and a user-friendly interface.
A winner from the shortlist will be chosen by the sponsor and announced at a virtual ceremony on May 28.
Congratulations to the shortlisted organisations and thank you to everyone who entered.
Fertility Innovation Shortlist
Future Fertility is not just transforming fertility care—we are defining its future.
With our new oocyte assessment feature—Euploidy Insights, a redesigned oocyte quality report experience, and ongoing scientific validation research, we’re setting new benchmarks for AI in reproductive health.
By integrating cutting-edge AI technology, clinical research, and patient-centered design, we are revolutionizing fertility care—empowering patients, supporting clinicians, and shaping the next era of reproductive medicine.
Gameet is a biotechnology startup that aims to transform assisted reproduction treatments, optimising the generation of healthy human embryos by emulating the natural processes of gamete selection and maturation in a 3D printed microdevice.
Our device improve the quality of the embryos obtained, offering a more efficient, consistent, profitable and therefore more accessible alternative for couples who resort to fertility treatments
GAMEET acts as a miniature embryo factory, where all the critical processes of IVF are performed within the same device.
MatriceLab’s pioneering endometrial immunology test is the result of more than 10 years of research.
Combined with precision therapy, it gives women in Assisted Reproductive Therapy a better chance of successful embryo implantation.
The MatriceLab team continues its research and development work to fight against infertility and to accompany patients and couples in their life projects.
As an independent research and innovation laboratory, MatriceLab is developing an ever more complete and efficient pathway for the distribution of its first diagnostic test to the greatest number of people throughout France and internationally.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.
